AGER and type 2 diabetes mellitus: Our previous study, performed in patients with type 2 diabetes, demonstrated AGER overexpression only in PBMC showing poor osteogenic differentiation ability but not in the PBMC showing preserved osteogenic differentiation (37), suggesting a linkage between AGER overexpression and a defect in osteogenic differentiation in PBMC derived from individuals with type 2 diabetes.